Physicians' Academy for Cardiovascular Education

Promise of epigenetic modulation as a target in atherosclerotic patients

Aug. 26, 2017 - Barcelona, Spain - Erik SG Stroes, MD, Amsterdam, the Netherlands - PACE-CME symposium at ESC 2017

This lecture was part of a CME accredited symposium: Managing Diabetes & CVD: Is epigenetics a new way forward? held at ESC 2017 in Barcelona

Educational information

The educational objectives of this symposium were to:

Faculty

Erik Stroes, MD, is Internist Vascular Medicine, Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands

CME Accreditation

This programme was accredited by the European Board for Accreditation in Cardiology (EBAC) for 1 hour of external CME credit(s).

Disclosures

This symposum was supported by an unrestricted educational grant provided by Resverlogix

Biography, Abstract and Keyslides View slides of this lecture